KENNEDY CAPITAL MANAGEMENT LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 884589
ST LOUIS, MO
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,428,049
+$1,977,815 QoQ
Shares Held
134,019
-2.2% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#61
of 341 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. PTGX ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
This page
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,428,049 | 134,019 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,450,234 | 137,099 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $19,340,918 | 221,444 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,846,469 | 208,437 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,455,370 | 134,890 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,649,693 | 137,504 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,410,903 | 321,526 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,016,485 | 267,033 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,051,341 | 290,082 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,623,107 | 298,068 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,988,834 | 304,790 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,329,827 | 319,534 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,148,757 | 403,648 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,619,486 | 331,282 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,819,951 | 350,133 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $835,303 | 99,087 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $784,482 | 99,176 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,303,235 | 97,265 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,604,474 | 105,394 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,989,335 | 112,265 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,228,981 | 71,947 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,955,916 | 75,518 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||